Solara Active Pharma Sciences Ltd Achieves Upper Circuit Limit Amid Strong Trading Activity
Solara Active Pharma Sciences Ltd's stock reached its upper circuit limit today, hitting an intraday high of Rs 530.65. The stock outperformed its sector, with notable trading activity and a total volume of approximately 0.39 lakh shares. Its performance reflects strong market interest and resilience in the pharmaceuticals sector.
Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has made headlines today as its stock hit the upper circuit limit. The stock reached an impressive intraday high of Rs 530.65, reflecting a notable change of Rs 19.55 or 3.87% from its last traded price of Rs 524.95. The stock's performance today outpaced its sector by 3.23%, showcasing its strength in a competitive market. With a total traded volume of approximately 0.39 lakh shares and a turnover of Rs 2.04 crore, the trading activity indicates a robust interest in the stock. The price band for the day was set at 5%, allowing for significant movement within the trading session.
In terms of moving averages, Solara's stock is currently above its 5-day and 20-day averages, although it remains below the 50-day, 100-day, and 200-day averages. Despite a slight decline in delivery volume, the stock maintains adequate liquidity for trading, with a delivery volume of 60.42k shares noted on March 20.
Overall, Solara Active Pharma Sciences Ltd's performance today highlights its resilience and market position within the pharmaceuticals sector, marking a significant day for the company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
